SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?


To: pz who wrote (956)9/21/1999 5:42:00 PM
From: Mad2  Respond to of 5582
 
No, when I do I'll let you know. Was short last Jan and covered a couple weeks later at 10.
I'd be short right now, however I like to sell at the top or after the top has clearly been idenitified. Only thing holding me back is the potential hype surrounding the "possible" publication of some study in NEJM.....If one comes out then its time to short. Other thing I'll watch is GUMM's quarterly reports for any sign of a problem. Not sure if it'll be self evident in 3rd qtr as they fill the pipline and may not book any avertizing cost, certianly by the 4th qtr report problems will be discernable as sales will pretty much be in for the winter season. Thus GUMM should be on the slipery side by January in my opinion. Could happen sooner, that's the danger going long with this one. Not the kinda stock you want to average down on once it starts to go, as evidenced by the QGLY chart (and that happened in a bull market!
Mad2